Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling

被引:37
作者
Bisht, Kavita [1 ,2 ]
Wegiel, Barbara [2 ]
Tampe, Jens [3 ]
Neubauer, Oliver [4 ]
Wagner, Karl-Heinz [4 ]
Otterbein, Leo E. [2 ]
Bulmer, Andrew C. [1 ]
机构
[1] Griffith Univ, Griffith Hlth Inst, Heart Fdn Res Ctr, Gold Coast, Australia
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[3] Griffith Univ, Griffith Enterprise, Nathan, Qld 4111, Australia
[4] Univ Vienna, Dept Nutr Sci, Vienna, Austria
基金
奥地利科学基金会;
关键词
Macrophage; Inflammation; mTOR; HEME CATABOLISM; LIPOPOLYSACCHARIDE; INHIBITION; ACTIVATION; ATHEROSCLEROSIS; MACROPHAGES; BILIRUBIN; APOPTOSIS; REDUCTASE; PATHWAYS;
D O I
10.1016/j.bbrc.2014.04.150
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Macrophages play a crucial role in the maintenance and resolution of inflammation and express a number of pro- and anti-inflammatory molecules in response to stressors. Among them, the complement receptor 5a (C5aR) plays an integral role in the development of inflammatory disorders. Biliverdin and bilirubin, products of heme catabolism, exert anti-inflammatory effects and inhibit complement activation. Here, we define the effects of biliverdin on C5aR expression in macrophages and the roles of Akt and mammalian target of rapamycin (mTOR) in these responses. Biliverdin administration inhibited lipopolysaccharide (LPS)-induced C5aR expression (without altering basal expression), an effect partially blocked by rapamycin, an inhibitor of mTOR signaling. Biliverdin also reduced LPS-dependent expression of the pro-inflammatory cytokines TNF-alpha and IL-6. Collectively, these data indicate that biliverdin regulates LPS-mediated expression of C5aR via the mTOR pathway, revealing an additional mechanism underlying biliverdin's anti-inflammatory effects. (C) 2014 The Authors. Published by Elsevier Inc.
引用
收藏
页码:94 / 99
页数:6
相关论文
共 33 条
[1]
Complement activation and disease: protective effects of hyperbilirubinaemia [J].
Basiglio, Cecilia L. ;
Arriaga, Sandra M. ;
Pelusa, Fabian ;
Almara, Adriana M. ;
Kapitulnik, Jaime ;
Mottino, Aldo D. .
CLINICAL SCIENCE, 2010, 118 (1-2) :99-113
[2]
Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome [J].
Boon, Ai-Ching ;
Hawkins, Clare L. ;
Bisht, Kavita ;
Coombes, Jeff S. ;
Bakrania, Bhavisha ;
Wagner, Karl-Heinz ;
Bulmer, Andrew C. .
FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (10) :2120-2127
[3]
Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration [J].
Bulmer, A. C. ;
Coombes, J. S. ;
Blanchfield, J. T. ;
Toth, I. ;
Fassett, R. G. ;
Taylor, S. M. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (07) :1857-1870
[4]
New Insights of an Old Defense System: Structure, Function, and Clinical Relevance of the Complement System [J].
Ehrnthaller, Christian ;
Ignatius, Anita ;
Gebhard, Florian ;
Huber-Lang, Markus .
MOLECULAR MEDICINE, 2011, 17 (3-4) :317-329
[5]
PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES [J].
GEARING, AJH ;
BECKETT, P ;
CHRISTODOULOU, M ;
CHURCHILL, M ;
CLEMENTS, J ;
DAVIDSON, AH ;
DRUMMOND, AH ;
GALLOWAY, WA ;
GILBERT, R ;
GORDON, JL ;
LEBER, TM ;
MANGAN, M ;
MILLER, K ;
NAYEE, P ;
OWEN, K ;
PATEL, S ;
THOMAS, W ;
WELLS, G ;
WOOD, LM ;
WOOLLEY, K .
NATURE, 1994, 370 (6490) :555-557
[6]
Exploring the specificity of the PI3K family inhibitor LY294002 [J].
Gharbi, Severine I. ;
Zvelebil, Marketa J. ;
Shuttleworth, Stephen J. ;
Hancox, Tim ;
Saghir, Nahid ;
Timms, John F. ;
Waterfield, Michael D. .
BIOCHEMICAL JOURNAL, 2007, 404 :15-21
[7]
The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells [J].
Guha, M ;
Mackman, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32124-32132
[8]
Upstream and downstream of mTOR [J].
Hay, N ;
Sonenberg, N .
GENES & DEVELOPMENT, 2004, 18 (16) :1926-1945
[9]
Complement takes its Toll: an inflammatory crosstalk between Toll-like receptors and the receptors for the complement anaphylatoxin C5a [J].
Holst, B. ;
Raby, A. -C. ;
Hall, J. E. ;
Labeta, M. O. .
ANAESTHESIA, 2012, 67 (01) :60-64
[10]
Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin [J].
Kinderlerer, Anne R. ;
Gregoire, Isabel Pombo ;
Hamdulay, Shahir S. ;
Ali, Faisal ;
Steinberg, Rivka ;
Silva, Gabriela ;
Ali, Nadira ;
Wang, Bufei ;
Haskard, Dorian O. ;
Soares, Miguel P. ;
Mason, Justin C. .
BLOOD, 2009, 113 (07) :1598-1607